This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Csl Behring Lengnau Ag. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Elmar Raquet: Innovator in Blood Coagulation Treatment
Introduction
Elmar Raquet is a notable inventor based in Frankenberg, Germany. He has made significant contributions to the field of blood coagulation disorders through his innovative research and development.
Latest Patents
Raquet holds a patent for "Truncated von Willebrand factor polypeptides for extravascular administration in the treatment or prophylaxis of a blood coagulation disorder." This invention involves a recombinant polypeptide that comprises a truncated von Willebrand Factor (VWF) for use in treating or preventing blood coagulation disorders. The treatment includes administering the recombinant polypeptide along with a Factor VIII protein (FVIII) extravascularly to a subject with a blood coagulation disorder. The recombinant polypeptide is designed to bind to FVIII, with a molar ratio of the recombinant polypeptide to FVIII being higher than 50. Raquet's work in this area has the potential to improve treatment outcomes for patients suffering from these disorders.
Career Highlights
Elmar Raquet is associated with Csl Behring Lengnau AG, where he continues to advance his research in blood coagulation. His expertise and innovative approach have positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Raquet collaborates with talented professionals in his field, including Sabine Pestel and Thomas Weimer. Their combined efforts contribute to the advancement of research and development in blood coagulation treatments.
Conclusion
Elmar Raquet's contributions to the field of blood coagulation disorders through his innovative patent highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.